KOSMOS BIOTHERAPEUTICS
Kosmos Biotherapeutics a preclinical-stage biopharmaceutical company developing an astrobiological therapeutic platform focused on the treatment of post-evolutionary disease in zero-gravity celestial settings.
KOSMOS BIOTHERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active
Similar Organizations
Palisade Therapeutics
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
Rimon Therapeutics
Rimon Therapeutics develops Theramers, a therapeutic polymer to treat chronic wounds.
More informations about "Kosmos Biotherapeutics"
Kosmos Biotherapeutics 2025 Company Profile: Valuation, Funding ...
When was Kosmos Biotherapeutics founded? Kosmos Biotherapeutics was founded in 2010. Where is Kosmos Biotherapeutics headquartered? Kosmos Biotherapeutics is headquartered …See details»
Kosmos Biotherapeutics - Crunchbase Company Profile & Funding
Organization. Kosmos Biotherapeutics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Kosmos Biotherapeutics develops an astrobiological …See details»
Kosmos Biotherapeutics - Company Profile and News
Company profile page for Kosmos Biotherapeutics including stock price, company news, executives, board members, and contact informationSee details»
Kosmos Biotherapeutics | Biotechnology, Medical, Therapeutics
Crystal Ball Ventures Investor Profile: Portfolio & Exits - PitchBook. Kosmos Biotherapeutics: 01-Mar-2021: 000000000 00000000: To view Crystal Ball Ventures’s complete exits history, …See details»
Kosmos Biotherapeutics Inc Company Profile, Financial and …
DigitGaps report on Kosmos Biotherapeutics Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
What does kosmos biotherapeutics mean? - Definitions.net
What does kosmos biotherapeutics mean? Information and translations of kosmos biotherapeutics in the most comprehensive dictionary definitions resource on the web. LoginSee details»
Crystal Ball Ventures investment portfolio | PitchBook
Jan 4, 2010 Crystal Ball Ventures's latest investment was on 04-Jan-2010 in Kosmos Biotherapeutics, a company within the Biotechnology industry. Data Transparency. Meet our …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
KBI Biopharma | Contract Development and Manufacturing …
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical …See details»
kosmos – FULL-TIME AND REMOTE JOBS
KOSMOS understands leadership, people who lead and the impact these individuals have on society. We leverage our experience and insight in strategic partnerships with clients to deliver …See details»
Kosmos Biotherapeutics - Crunchbase
Kosmos Biotherapeutics develops an astrobiological therapeutic platform for the treatment of post-evolutionary diseases.See details»
Developing Biotherapeutics in the New Decade - PMC
We selected original research articles and reviews on bioprocessing, developability and manufacturability of biologics, formulation and process development, and immunogenicity …See details»
WHO Questions and Answers: Similar Biotherapeutic Products
Mar 19, 2018 Overview . The WHO Guidelines on evaluation of similar biotherapeutic products (SBPs) were adopted by the WHO Expert Committee on Biological Standardization (ECBS) in …See details»
Biotherapeutic medicines: a winning formula for patients
Apr 25, 2016 Biotherapeutics play an important role in modern medicine and have a profound impact on patients with serious diseases. A biotherapeutic is a medical product manufactured …See details»
KOREAN SOCIETY OF MEDICAL ONCOLOGY - ksmo.or.kr
Introduction to the KOSMOS Ⅱ Study. With the advent of diagnostic methods such as Next-Generation Sequencing (NGS) and the development of targeted therapies and novel …See details»
NASA Bioventures investment portfolio - PitchBook
Kosmos Biotherapeutics: 04-Jan-2010: Biotechnology: Generating Revenue: To view NASA Bioventures’s complete investments history, request access » Want detailed data on 3M+ …See details»
Biosimilars - World Health Organization (WHO)
The scope of the revised Guidelines was expanded to include the evaluation of biological products other than biotherapeutics, with a corresponding shift to the use of the term …See details»
Sonoma Biotherapeutics
Sonoma Biotherapeutics to Present Preclinical Data from Novel T reg Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2023. Learn More. View all press …See details»
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an ...
May 12, 2022 Patient organization funding Payments to healthcare professionals Public policy A living wage ... an Observational Study (KOSMOS) ClinicalTrials.gov Identifier: NCT05285904. …See details»
WHO guidelines on biosimilars: Toward improved access to safe …
The World Health Assembly resolution on access to biotherapeutics in 2014 urges WHO and Member States to facilitate access to biotherapeutics while ensuring their quality, safety, and …See details»